Prevalence of depressive symptoms and their impact on quality of life in patients with drug-resistant focal epilepsy (IMDYVA study)
Open Access
- 1 February 2015
- journal article
- research article
- Published by Elsevier in Epilepsy Research
- Vol. 110, 157-165
Abstract
No abstract availableKeywords
Funding Information
- Bial Industrial Farmacéutica Spain, S.A.
- EISAI Farmacéutica S.A.
This publication has 28 references indexed in Scilit:
- Determinants of Quality of Life in People with EpilepsyNeurologic Clinics, 2009
- Identifying depression in epilepsy in a busy clinical setting is enhanced with systematic screeningSeizure: European Journal of Epilepsy, 2009
- The descriptive epidemiology of epilepsy—A reviewEpilepsy Research, 2009
- ILAE Treatment Guidelines: Evidence‐based Analysis of Antiepileptic Drug Efficacy and Effectiveness as Initial Monotherapy for Epileptic Seizures and SyndromesEpilepsia, 2006
- Rapid detection of major depression in epilepsy: a multicentre studyThe Lancet Neurology, 2006
- Depression but not seizure frequency predicts quality of life in treatment-resistant epilepsyNeurology, 2004
- Staged approach to epilepsy managementNeurology, 2002
- Psychiatric Comorbidity in Chronic Epilepsy: Identification, Consequences, and Treatment of Major DepressionEpilepsia, 2000
- Development and Cross‐Cultural Translations of a 31‐Item Quality of Life in Epilepsy InventoryEpilepsia, 1998
- Quality of Life of People with Epilepsy: A European StudyEpilepsia, 1997